Mature autologous dendritic cell vaccines in advanced non-small cell lung cancer: a phase I pilot study

BACKGROUND: Overall therapeutic outcomes of advanced non-small-cell lung cancer (NSCLC) are poor. The dendritic cell (DC) immunotherapy has been developed as a new strategy for the treatment of lung cancer. The purpose of this study was to evaluate the feasibility, safety and immunologic responses i...

Descripción completa

Detalles Bibliográficos
Autores principales: Perroud, Maurício W, Honma, Helen N, Barbeiro, Aristóteles S, Gilli, Simone CO, Almeida, Maria T, Vassallo, José, Saad, Sara TO, Zambon, Lair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135553/
https://www.ncbi.nlm.nih.gov/pubmed/21682877
http://dx.doi.org/10.1186/1756-9966-30-65

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135553/
https://www.ncbi.nlm.nih.gov/pubmed/21682877
http://dx.doi.org/10.1186/1756-9966-30-65

Ejemplares similares